FIELD: medicine.
SUBSTANCE: antagonist of interleukin-1 receptor - raleykin is additionally introduced in dose 15-25 mg per kilogram of body weight at the background of basic and differentiated therapy.
EFFECT: effective recovery of disorders, resulting from stroke, and reduction of possibility of development of infectious complications and brain oedema due to increase of organism's immune status.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS (OPTIONS) | 2017 |
|
RU2659674C1 |
| METHOD FOR TREATING ACUTE CEREBRAL STROKE CASES | 2005 |
|
RU2268064C1 |
| METHOD FOR DETERMINING RISK OF OCCASIONAL CEREBRAL STROKE IN PATIENTS UNDERWENT CEREBROVASCULAR ACCIDENT | 2018 |
|
RU2669895C1 |
| AGENT FOR TREATMENT OF ACUTE AND CHRONIC DISTURBANCES OF CEREBRAL CIRCULATION, INCLUDING STROKE ON BASIS OF HYDROGENATED PYRIDO (4,3-b)INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND METHOD OF ITS APPLICATION | 2006 |
|
RU2340342C2 |
| METHOD OF ACUTE CEREBRAL CIRCULATION DISORDER COURSE FORECAST | 2007 |
|
RU2327994C1 |
| METHOD FOR PREDICTING RISK OF CEREBRAL COMPLICATIONS FOLLOWING ISCHEMIC STROKE | 2014 |
|
RU2545435C1 |
| METHOD OF TREATING CEREBRAL OEDEMA | 2014 |
|
RU2563123C1 |
| COMPOSITION FOR NEUROPROTECTION AND STIMULATION OF BRAIN NEUROREGENERATION AFTER INJURY, AGENT BASED ON IT, A METHOD OF ITS PRODUCTION AND USE | 2022 |
|
RU2803286C1 |
| METHOD OF CEREBRAL ISCHEMIC INSULT TREATMENT | 1996 |
|
RU2145895C1 |
| METHOD FOR TREATING STROKE CASES | 2004 |
|
RU2283121C2 |
